Reaction
Blood Sodium Abnormal reporting signals
As of the last recalculation, Blood Sodium Abnormal appears in 1,047 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is TOLVAPTAN (PRR 39.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tolvaptan | 28 | 39.3 | 39.4 |
| Dextrose | 11 | 16.8 | 16.8 |
| Dextrose Monohydrate | 11 | 16.5 | 16.5 |
| Nebivolol | 10 | 12.6 | 12.6 |
| Ribociclib | 17 | 10.9 | 10.9 |
| Acalabrutinib | 5 | 8.2 | 8.2 |
| Osimertinib | 13 | 8.2 | 8.2 |
| Cabozantinib | 14 | 5.9 | 5.9 |
| Olaparib | 6 | 5.7 | 5.7 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 8 | 5.2 | 5.2 |
| Lenvatinib | 8 | 4.9 | 4.9 |
| Sacubitril And Valsartan | 26 | 4.5 | 4.5 |
| Patiromer | 3 | 4.3 | 4.3 |
| Abaloparatide | 5 | 3.4 | 3.4 |
| Valbenazine | 4 | 3.2 | 3.2 |